Glenmark Life Sciences Q2 PAT rises 11% to Rs 119 crore

Glenmark Life Sciences Q2 Results: Glenmark Life Sciences said its profit after tax rose 11 per cent year-on-year to Rs 119 crore for the second quarter ended September 30, 2023.

Glenmark Life Sciences Q2 PAT rises 11% to Rs 119 crore
Revenue from operations increased to Rs 595 crore during the quarter, a year-on-year growth of 17 per cent, Glenmark Life Sciences said in a regulatory filing. Pic: glenmarklifesciences.com

Glenmark Life Sciences Q2 Results: Glenmark Life Sciences on Friday said its profit after tax rose 11 per cent year-on-year to Rs 119 crore for the second quarter ended September 30, 2023.

Revenue from operations increased to Rs 595 crore during the quarter, a year-on-year growth of 17 per cent, Glenmark Life Sciences said in a regulatory filing.

"Geographically, regulated markets including the US, Europe, LATAM and India continue to spearhead our growth," Glenmark Life Sciences MD and CEO Yasir Rawjee said.

LATAM refers to Latin American countries.

Looking ahead, enhanced visibility towards the H2 FY24 demand for generic API and CDMO business bolsters the company's confidence in delivering growth in FY24, he added.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.   

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-mutual-fund-sip-retirement-corpus-planning-calculator-how-many-years-it-will-take-to-reach-inr-rs-30000000-with-4000-5000-and-6000-monthly-investment-market-linked-return-324325

Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000

https://www.zeebiz.com/personal-finance/news-sip-mutual-fund-power-of-compounding-retirement-corpus-planning-calculator-salary-inr-rs-25000-per-month-is-it-possible-to-create-over-26367030-fund-calculations-324366

Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations

https://www.zeebiz.com/markets/stocks/photo-gallery-smallcap-stock-to-buy-for-long-term-new-year-pick-by-anil-singhvi-liquor-share-tilaknagar-inudstries-share-price-target-324475

Liquor stock under Rs 300: Can this smallcap scrip double your money in 1-2 years? Check targets by Anil Singhvi

https://www.zeebiz.com/personal-finance/news-reduce-home-loan-emi-or-reduce-tenure-rs-75-lakh-25-year-home-loan-which-option-can-save-rs-25-lakh-and-64-months-and-how-know-here-324393

Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-large-and-mid-cap-sip-mutual-funds-with-highest-best-xirr-returns-in-5-years-no-1-scheme-has-turned-rs-inr-15000-monthly-investment-into-rs-2054384-uti-icici-hdfc-bank-hsbc-quant-motilal-324344

Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-pnb-hdfc-bank-3-year-senior-citizen-fd-fixed-deposit-interest-rate-maturity-return-calculator-which-bank-gives-highest-on-inr-rs-500000-investment-state-bank-of-india-punjab-national-guaranteed-return-scheme-324094

Senior Citizen FD: SBI 3-year FD vs PNB 3-year FD vs HDFC Bank 3-year FD; which FD will give highest return on Rs 5 lakh investment

Written By: PTI
Updated: Fri, Oct 20, 2023
06:34 PM IST
PTI
RELATED NEWS
Glenmark Life Sciences Q3 results: Net profit rises 13% at Rs 119 crore Glenmark Life Sciences Q3 results: Net profit rises 13% at Rs 119 crore
1,150% dividend: This pharma stock to trade ex-date on Tuesday 1,150% dividend: This pharma stock to trade ex-date on Tuesday
Glenmark Life Sciences announces interim dividend for FY24 Glenmark Life Sciences announces interim dividend for FY24
Glenmark Life Sciences board to consider Q2 results, dividend on this date Glenmark Life Sciences board to consider Q2 results, dividend on this date
Glenmark Pharma share jumps over 6% as S&P Global upgrades rating from 'stable' to 'positive' Glenmark Pharma share jumps over 6% as S&P Global upgrades rating from 'stable' to 'positive'

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x